Pain Management Drugs Market – Global Industry Analysis and Forecast (2022-2029)

Pain Management Drugs Market was valued at US$ 38.91 Bn in 2021 and is expected to reach US$ 58.16 Bn by 2029, at a CAGR of 5.15% during a forecast period. The report includes an analysis of the impact of COVID-19 lockdown on the revenue of market leaders, followers, and disruptors. Since the lockdown was implemented differently in various regions and countries; the impact of the same is also seen differently by regions and segments. The report has covered the current short-term and long-term impact on the market, and it would help the decision-makers to prepare the outline and strategies for companies by region.
Global Pain Management Drugs Market
To know about the Research Methodology:-Request Free Sample Report

Pain Management Drugs Market Dynamics:

Pain management is used for treating all types of pain containing musculoskeletal, spinal, and neuropathic pain disorders. It is used to improve the quality of life of individuals suffering from pain. Growth in the geriatric population is the major factor that drives the growth of the global pain management market due to elderly people are more likely to suffer from joint pain as well as chronic disorders such as heart disease, stroke, diabetes, and cancer. The rise in alertness regarding the side effects of pain medication, and growing the occurrence & prevalence of chronic diseases are also boosting the growth of the market. Availability of alternative therapies and a rise in drug mistreatment are obstructing the growth of the pain management drugs market.

 Pain Management Drugs Market Segment Analysis:

Prescription of medicine is leading the market, owing to the drugs that are only available with a valid prescription from a doctor. Prescription drugs must pass through many clinical trial phases, approval by the food and drug administration (FDA), and observed for safety & side effects even after the drug is on the market. OTC drugs are available without consulting a prescriber or pharmacist, though the patient is to be aware of these drugs that still carry a risk. OTC drugs are monitored by the food and drug administration, but it is not as stringent as the process prescription drugs must go through. Migraine is very common, and it is a type of headache-related disorder with sensitivity towards odor, light, or acoustics. Migraines can be treated with abortive and preventive medicines. Abortive medications work quickly and are especially useful for people who have nausea & vomiting related to their migraines. Abortive medications can be taken by self-injection, mouth, and skin patch. Fibromyalgia is a common type of chronic pain where the patient suffers from musculoskeletal pain along with memory, fatigue, sleep, and mood issues.

Pain Management Drugs Market Regional Insights:

Asia-Pacific is estimated to be the fastest-growing region for the pain management drugs market owing to the presence of a larger patient pool and the growth in healthcare expenditure in this region. Japan is the largest contributor and China & India are the fastest-growing countries in the Asia-Pacific region in the global pain management drugs markets. The report covers a comprehensive study of major market drivers, restraints, opportunities, challenges, PESTEL, Porters, SWOT, and technological forecasting in the market.

Pain Management Drugs Market, Key Highlights:

• Global Pain Management Drugs Market analysis and forecast, in terms of value. • Comprehensive study and analysis of market drivers, restraints and opportunities influencing the growth of the Global Pain Management Drugs Market • Global Pain Management Drugs Market segmentation on the basis of type, source, end-user, and region (country-wise) has been provided. • Global Pain Management Drugs Market strategic analysis with respect to individual growth trends, future prospects along with the contribution of various sub-market stakeholders have been considered under the scope of study. • Global Pain Management Drugs Market analysis and forecast for five major regions namely North America, Europe, Asia Pacific, the Middle East & Africa (MEA) and Latin America along with country-wise segmentation. • Profiles of key industry players, their strategic perspective, market positioning and analysis of core competencies are further profiled. • Competitive developments, investments, strategic expansion and competitive landscape of the key players operating in the Global Pain Management Drugs Market are also profiled.

The Scope of the Global Pain Management Drugs Market:  Inquire before buying

Global Pain Management Drugs Market
Report Coverage Details
Base Year: 2021 Forecast Period: 2022-2029
Historical Data: 2017 to 2021 Market Size in 2021: US $ 38.91 Bn.
Forecast Period 2022 to 2029 CAGR: 5.15% Market Size in 2029: US $ 58.16 Bn.
Segments Covered: by Category • Prescription-Based Drugs • Over-The-Counter (OTC) Drugs
by Therapeutic Indication • Post-Operative Pain • Low-Back Pain • Rheumatoid Arthritis Pain • Osteoarthritis Pain • Cancer Pain • Migraine • Neuropathic Pain • Fibromyalgia • Others
by Brands • Maxalt • Zomig • Qutenza • Lidoderm • Savella • Imitrex • Voltaren Gel • Celebrex • Cymbalta • Others

Global Pain Management Drugs Market, by Region:

• North America • Europe • Asia-Pacific • South America • Middle East & Africa

Global Pain Management Drugs Market Key Players:

Pfizer, Inc. • Purdue Pharma L.P. • Eli Lilly And Company • GlaxoSmithKline • Johnson & Johnson • Endo Pharmaceuticals • Allergen Inc. • Bayer AG • Bristol-Myers Squibb • Valeant Pharmaceuticals International Inc. • Boehringer Ingelheim • Sorrento Therapeutics • WEX Pharmaceuticals • Zynerba Pharmaceuticals • GSK • Grunenthal • AstraZeneca • Depomed • Teva • Allergan Frequently Asked Questions: 1] What segments are covered in the Global Pain management drugs Market report? Ans. The segments covered in the Market report are based on Therapeutic Indication, category, and brand. 2] Which region is expected to hold the highest share in the Global  Market? Ans. The North American region is expected to hold the highest share in Market. 3] What is the market size of the Global  Market by 2029? Ans. The market size of the Global  Market by 2029 is expected to reach US$ 58.16 Bn. 4] What is the forecast period for the Global Market? Ans. The forecast period for the Market is 2022-2029. 5] What was the market size of the Global Market in 2021? Ans. The market size of the Global  Market in 2021 was valued at US$ 38.91Bn.

Global pain management drugs market

1. Preface 1.1. Research Objectives 1.2. Report Scope and Market Segmentation 2. Assumptions and Research Methodology 2.1. Abbreviations 3. Executive Summary 3.1. Global Pain Management Drugs Market Size, by Market Value (US$ Bn) and Market 4. Market Overview 4.1. Introduction 4.2. Market Dynamics 4.3. Drivers and Restraints Snapshot Analysis 4.3.1. Drivers 4.3.2. Restraints 4.3.3. Opportunities 4.3.4. Porter’s Analysis 4.3.5. Value Chain Analysis 4.3.6. SWOT Analysis 4.3.7. Key Trends in Global Pain Management Drugs Market 5. Global Pain Management Drugs Market Analysis and Forecast 5.1. Global Pain Management Drugs Market Size& Y-o-Y Growth Analysis 5.1.1. North America 5.1.2. Europe 5.1.3. Asia Pacific 5.1.4. Middle East & Africa 5.1.5. South America 6. Global Pain Management Drugs Market Analysis and Forecast, By Category 6.1. Introduction and Definition 6.2. Global Pain Management Drugs Market Value Share Analysis, By Category 6.3. Global Pain Management Drugs Market Size (US$ Bn) Forecast, By Category 6.4. Global Pain Management Drugs Market Analysis, By Category 6.5. Global Pain Management Drugs Market Attractiveness Analysis, By Category 6.6. Key Trends 6.6.1. Key Developments 7. Global Pain Management Drugs Market Analysis and Forecast, By Therapeutic Indications 7.1. Introduction and Definition 7.2. Global Pain Management Drugs Market Value Share Analysis, By Therapeutic Indications 7.3. Global Pain Management Drugs Market Size (US$ Bn) Forecast, By Therapeutic Indications 7.4. Global Pain Management Drugs Market Analysis, By Therapeutic Indications 7.5. Global Pain Management Drugs Market Attractiveness Analysis, By Therapeutic Indications 7.6. Key Trends 7.6.1. Key Developments 8. Global Pain Management Drugs Market Analysis and Forecast, By Brands 8.1. Introduction and Definition 8.2. Global Pain Management Drugs Market Value Share Analysis, By Brands 8.3. Global Pain Management Drugs Market Size (US$ Bn) Forecast, By Brands 8.4. Global Pain Management Drugs Market Analysis, By Brands 8.5. Global Pain Management Drugs Market Attractiveness Analysis, By Brands 8.6. Key Trends 8.6.1. Key Developments 9. Global Pain Management Drugs Market Analysis, by Region 9.1. Global Pain Management Drugs Market Value Share Analysis, by Region 9.2. Global Pain Management Drugs Market Size (US$ Bn) Forecast, by Region 9.3. Global Pain Management Drugs Market Attractiveness Analysis, by Region 9.4. Key Trends 9.4.1. Key Developments 10. North America Pain Management Drugs Market Analysis 10.1. North America Pain Management Drugs Market Overview 10.2. North America Pain Management Drugs Market Value Share Analysis, By Category 10.3. North America Pain Management Drugs Market Forecast, By Category 10.3.1. Prescription-Based Drugs 10.3.2. Over-The-Counter (OTC) Drugs 10.4. North America Pain Management Drugs Market Value Share Analysis, By Therapeutic Indications 10.5. North America Pain Management Drugs Market Forecast, By Therapeutic Indications 10.5.1. Post-Operative Pain 10.5.2. Low-Back Pain 10.5.3. Rheumatoid Arthritis Pain 10.5.4. Osteoarthritis Pain 10.5.5. Cancer Pain 10.5.6. Migraine 10.5.7. Neuropathic Pain 10.5.8. Fibromyalgia 10.5.9. Others 10.6. North America Pain Management Drugs Market Value Share Analysis, By Brands 10.7. North America Pain Management Drugs Market Forecast, By Brands 10.7.1. Maxalt 10.7.2. Zomig 10.7.3. Qutenza 10.7.4. Lidoderm 10.7.5. Savella 10.7.6. Imitrex 10.7.7. Voltaren Gel 10.7.8. Celebrex 10.7.9. Cymbalta 10.7.10. Others 10.8. North America Pain Management Drugs Market Value Share Analysis, by Country 10.9. North America Pain Management Drugs Market Forecast, by Country 10.9.1. U.S. 10.9.2. Canada 10.10. North America Pain Management Drugs Market Analysis, by Country 10.11. U.S. Pain Management Drugs Market Forecast, By Category 10.11.1. Prescription-Based Drugs 10.11.2. Over-The-Counter (OTC) Drugs 10.12. U.S. Pain Management Drugs Market Forecast, By Therapeutic Indications 10.12.1. Post-Operative Pain 10.12.2. Low-Back Pain 10.12.3. Rheumatoid Arthritis Pain 10.12.4. Osteoarthritis Pain 10.12.5. Cancer Pain 10.12.6. Migraine 10.12.7. Neuropathic Pain 10.12.8. Fibromyalgia 10.12.9. Others 10.13. U.S. Pain Management Drugs Market Forecast, By Brands 10.13.1. Maxalt 10.13.2. Zomig 10.13.3. Qutenza 10.13.4. Lidoderm 10.13.5. Savella 10.13.6. Imitrex 10.13.7. Voltaren Gel 10.13.8. Celebrex 10.13.9. Cymbalta 10.13.10. Others 10.14. Canada Pain Management Drugs Market Forecast, By Category 10.14.1. Prescription-Based Drugs 10.14.2. Over-The-Counter (OTC) Drugs 10.15. Canada Pain Management Drugs Market Forecast, By Therapeutic Indications 10.15.1. Post-Operative Pain 10.15.2. Low-Back Pain 10.15.3. Rheumatoid Arthritis Pain 10.15.4. Osteoarthritis Pain 10.15.5. Cancer Pain 10.15.6. Migraine 10.15.7. Neuropathic Pain 10.15.8. Fibromyalgia 10.15.9. Others 10.16. Canada Pain Management Drugs Market Forecast, By Brands 10.16.1. Maxalt 10.16.2. Zomig 10.16.3. Qutenza 10.16.4. Lidoderm 10.16.5. Savella 10.16.6. Imitrex 10.16.7. Voltaren Gel 10.16.8. Celebrex 10.16.9. Cymbalta 10.16.10. Others 10.17. North America Pain Management Drugs Market Attractiveness Analysis 10.17.1. By Category 10.17.2. By Therapeutic Indications 10.17.3. By Brands 10.18. PEST Analysis 10.19. Key Trends 10.19.1. Key Developments 11. Europe Pain Management Drugs Market Analysis 11.1. Europe Pain Management Drugs Market Overview 11.2. Europe Pain Management Drugs Market Value Share Analysis, By Category 11.3. Europe Pain Management Drugs Market Forecast, By Category 11.3.1. Prescription-Based Drugs 11.3.2. Over-The-Counter (OTC) Drugs 11.4. Europe Pain Management Drugs Market Value Share Analysis, By Therapeutic Indications 11.5. Europe Pain Management Drugs Market Forecast, By Therapeutic Indications 11.5.1. Post-Operative Pain 11.5.2. Low-Back Pain 11.5.3. Rheumatoid Arthritis Pain 11.5.4. Osteoarthritis Pain 11.5.5. Cancer Pain 11.5.6. Migraine 11.5.7. Neuropathic Pain 11.5.8. Fibromyalgia 11.5.9. Others 11.6. Europe Pain Management Drugs Market Value Share Analysis, By Brands 11.7. Europe Pain Management Drugs Market Forecast, By Brands 11.7.1. Maxalt 11.7.2. Zomig 11.7.3. Qutenza 11.7.4. Lidoderm 11.7.5. Savella 11.7.6. Imitrex 11.7.7. Voltaren Gel 11.7.8. Celebrex 11.7.9. Cymbalta 11.7.10. Others 11.8. Europe Pain Management Drugs Market Value Share Analysis, by Country 11.9. Europe Pain Management Drugs Market Forecast, by Country 11.9.1. Germany 11.9.2. U.K. 11.9.3. France 11.9.4. Italy 11.9.5. Spain 11.9.6. Rest of Europe 11.10. Europe Pain Management Drugs Market Analysis, by Country/ Sub-region 11.11. Germany Pain Management Drugs Market Forecast, By Category 11.11.1. Prescription-Based Drugs 11.11.2. Over-The-Counter (OTC) Drugs 11.12. Germany Pain Management Drugs Market Forecast, By Therapeutic Indications 11.12.1. Post-Operative Pain 11.12.2. Low-Back Pain 11.12.3. Rheumatoid Arthritis Pain 11.12.4. Osteoarthritis Pain 11.12.5. Cancer Pain 11.12.6. Migraine 11.12.7. Neuropathic Pain 11.12.8. Fibromyalgia 11.12.9. Others 11.13. Germany Pain Management Drugs Market Forecast, By Brands 11.13.1. Maxalt 11.13.2. Zomig 11.13.3. Qutenza 11.13.4. Lidoderm 11.13.5. Savella 11.13.6. Imitrex 11.13.7. Voltaren Gel 11.13.8. Celebrex 11.13.9. Cymbalta 11.13.10. Others 11.14. U.K. Pain Management Drugs Market Forecast, By Category 11.14.1. Prescription-Based Drugs 11.14.2. Over-The-Counter (OTC) Drugs 11.15. U.K. Pain Management Drugs Market Forecast, By Therapeutic Indications 11.15.1. Post-Operative Pain 11.15.2. Low-Back Pain 11.15.3. Rheumatoid Arthritis Pain 11.15.4. Osteoarthritis Pain 11.15.5. Cancer Pain 11.15.6. Migraine 11.15.7. Neuropathic Pain 11.15.8. Fibromyalgia 11.15.9. Others 11.16. U.K. Pain Management Drugs Market Forecast, By Brands 11.16.1. Maxalt 11.16.2. Zomig 11.16.3. Qutenza 11.16.4. Lidoderm 11.16.5. Savella 11.16.6. Imitrex 11.16.7. Voltaren Gel 11.16.8. Celebrex 11.16.9. Cymbalta 11.16.10. Others 11.17. France Pain Management Drugs Market Forecast, By Category 11.17.1. Prescription-Based Drugs 11.17.2. Over-The-Counter (OTC) Drugs 11.18. France Pain Management Drugs Market Forecast, By Therapeutic Indications 11.18.1. Post-Operative Pain 11.18.2. Low-Back Pain 11.18.3. Rheumatoid Arthritis Pain 11.18.4. Osteoarthritis Pain 11.18.5. Cancer Pain 11.18.6. Migraine 11.18.7. Neuropathic Pain 11.18.8. Fibromyalgia 11.18.9. Others 11.19. France Pain Management Drugs Market Forecast, By Brands 11.19.1. Maxalt 11.19.2. Zomig 11.19.3. Qutenza 11.19.4. Lidoderm 11.19.5. Savella 11.19.6. Imitrex 11.19.7. Voltaren Gel 11.19.8. Celebrex 11.19.9. Cymbalta 11.19.10. Others 11.20. Italy Pain Management Drugs Market Forecast, By Category 11.20.1. Prescription-Based Drugs 11.20.2. Over-The-Counter (OTC) Drugs 11.21. Italy Pain Management Drugs Market Forecast, By Therapeutic Indications 11.21.1. Post-Operative Pain 11.21.2. Low-Back Pain 11.21.3. Rheumatoid Arthritis Pain 11.21.4. Osteoarthritis Pain 11.21.5. Cancer Pain 11.21.6. Migraine 11.21.7. Neuropathic Pain 11.21.8. Fibromyalgia 11.21.9. Others 11.22. Italy Pain Management Drugs Market Forecast, By Brands 11.22.1. Maxalt 11.22.2. Zomig 11.22.3. Qutenza 11.22.4. Lidoderm 11.22.5. Savella 11.22.6. Imitrex 11.22.7. Voltaren Gel 11.22.8. Celebrex 11.22.9. Cymbalta 11.22.10. Others 11.23. Spain Pain Management Drugs Market Forecast, By Category 11.23.1. Prescription-Based Drugs 11.23.2. Over-The-Counter (OTC) Drugs 11.24. Spain Pain Management Drugs Market Forecast, By Therapeutic Indications 11.24.1. Post-Operative Pain 11.24.2. Low-Back Pain 11.24.3. Rheumatoid Arthritis Pain 11.24.4. Osteoarthritis Pain 11.24.5. Cancer Pain 11.24.6. Migraine 11.24.7. Neuropathic Pain 11.24.8. Fibromyalgia 11.24.9. Others 11.25. Spain Pain Management Drugs Market Forecast, By Brands 11.25.1. Maxalt 11.25.2. Zomig 11.25.3. Qutenza 11.25.4. Lidoderm 11.25.5. Savella 11.25.6. Imitrex 11.25.7. Voltaren Gel 11.25.8. Celebrex 11.25.9. Cymbalta 11.25.10. Others 11.26. Rest of Europe Pain Management Drugs Market Forecast, By Category 11.26.1. Prescription-Based Drugs 11.26.2. Over-The-Counter (OTC) Drugs 11.27. Rest of Europe Pain Management Drugs Market Forecast, By Therapeutic Indications 11.27.1. Post-Operative Pain 11.27.2. Low-Back Pain 11.27.3. Rheumatoid Arthritis Pain 11.27.4. Osteoarthritis Pain 11.27.5. Cancer Pain 11.27.6. Migraine 11.27.7. Neuropathic Pain 11.27.8. Fibromyalgia 11.27.9. Others 11.28. Rest of Europe Pain Management Drugs Market Forecast, By Brands 11.28.1. Maxalt 11.28.2. Zomig 11.28.3. Qutenza 11.28.4. Lidoderm 11.28.5. Savella 11.28.6. Imitrex 11.28.7. Voltaren Gel 11.28.8. Celebrex 11.28.9. Cymbalta 11.28.10. Others 11.29. Europe Pain Management Drugs Market Attractiveness Analysis 11.29.1. By Category 11.29.2. By Therapeutic Indications 11.29.3. By Brands 11.30. PEST Analysis 11.31. Key Trends 11.31.1. Key Developments 12. Asia Pacific Pain Management Drugs Market Analysis 12.1. Asia Pacific Pain Management Drugs Market Overview 12.2. Asia Pacific Pain Management Drugs Market Value Share Analysis, By Category 12.3. Asia Pacific Pain Management Drugs Market Forecast, By Category 12.3.1. Prescription-Based Drugs 12.3.2. Over-The-Counter (OTC) Drugs 12.4. Asia Pacific Pain Management Drugs Market Value Share Analysis, By Therapeutic Indications 12.5. Asia Pacific Pain Management Drugs Market Forecast, By Therapeutic Indications 12.5.1. Post-Operative Pain 12.5.2. Low-Back Pain 12.5.3. Rheumatoid Arthritis Pain 12.5.4. Osteoarthritis Pain 12.5.5. Cancer Pain 12.5.6. Migraine 12.5.7. Neuropathic Pain 12.5.8. Fibromyalgia 12.5.9. Others 12.6. Asia Pacific Pain Management Drugs Market Value Share Analysis, By Brands 12.7. Asia Pacific Pain Management Drugs Market Forecast, By Brands 12.7.1. Maxalt 12.7.2. Zomig 12.7.3. Qutenza 12.7.4. Lidoderm 12.7.5. Savella 12.7.6. Imitrex 12.7.7. Voltaren Gel 12.7.8. Celebrex 12.7.9. Cymbalta 12.7.10. Others 12.8. Asia Pacific Pain Management Drugs Market Value Share Analysis, by Country 12.9. Asia Pacific Pain Management Drugs Market Forecast, by Country 12.9.1. China 12.9.2. India 12.9.3. Japan 12.9.4. ASEAN 12.9.5. Rest of Asia Pacific 12.10. Asia Pacific Pain Management Drugs Market Analysis, by Country/ Sub-region 12.11. China Pain Management Drugs Market Forecast, By Category 12.11.1. Prescription-Based Drugs 12.11.2. Over-The-Counter (OTC) Drugs 12.12. China Pain Management Drugs Market Forecast, By Therapeutic Indications 12.12.1. Post-Operative Pain 12.12.2. Low-Back Pain 12.12.3. Rheumatoid Arthritis Pain 12.12.4. Osteoarthritis Pain 12.12.5. Cancer Pain 12.12.6. Migraine 12.12.7. Neuropathic Pain 12.12.8. Fibromyalgia 12.12.9. Others 12.13. China Pain Management Drugs Market Forecast, By Brands 12.13.1. Maxalt 12.13.2. Zomig 12.13.3. Qutenza 12.13.4. Lidoderm 12.13.5. Savella 12.13.6. Imitrex 12.13.7. Voltaren Gel 12.13.8. Celebrex 12.13.9. Cymbalta 12.13.10. Others 12.14. India Pain Management Drugs Market Forecast, By Category 12.14.1. Prescription-Based Drugs 12.14.2. Over-The-Counter (OTC) Drugs 12.15. India Pain Management Drugs Market Forecast, By Therapeutic Indications 12.15.1. Post-Operative Pain 12.15.2. Low-Back Pain 12.15.3. Rheumatoid Arthritis Pain 12.15.4. Osteoarthritis Pain 12.15.5. Cancer Pain 12.15.6. Migraine 12.15.7. Neuropathic Pain 12.15.8. Fibromyalgia 12.15.9. Others 12.16. India Pain Management Drugs Market Forecast, By Brands 12.16.1. Maxalt 12.16.2. Zomig 12.16.3. Qutenza 12.16.4. Lidoderm 12.16.5. Savella 12.16.6. Imitrex 12.16.7. Voltaren Gel 12.16.8. Celebrex 12.16.9. Cymbalta 12.16.10. Others 12.17. Japan Pain Management Drugs Market Forecast, By Category 12.17.1. Prescription-Based Drugs 12.17.2. Over-The-Counter (OTC) Drugs 12.18. Japan Pain Management Drugs Market Forecast, By Therapeutic Indications 12.18.1. Post-Operative Pain 12.18.2. Low-Back Pain 12.18.3. Rheumatoid Arthritis Pain 12.18.4. Osteoarthritis Pain 12.18.5. Cancer Pain 12.18.6. Migraine 12.18.7. Neuropathic Pain 12.18.8. Fibromyalgia 12.18.9. Others 12.19. Japan Pain Management Drugs Market Forecast, By Brands 12.19.1. Maxalt 12.19.2. Zomig 12.19.3. Qutenza 12.19.4. Lidoderm 12.19.5. Savella 12.19.6. Imitrex 12.19.7. Voltaren Gel 12.19.8. Celebrex 12.19.9. Cymbalta 12.19.10. Others 12.20. ASEAN Pain Management Drugs Market Forecast, By Category 12.20.1. Prescription-Based Drugs 12.20.2. Over-The-Counter (OTC) Drugs 12.21. ASEAN Pain Management Drugs Market Forecast, By Therapeutic Indications 12.21.1. Post-Operative Pain 12.21.2. Low-Back Pain 12.21.3. Rheumatoid Arthritis Pain 12.21.4. Osteoarthritis Pain 12.21.5. Cancer Pain 12.21.6. Migraine 12.21.7. Neuropathic Pain 12.21.8. Fibromyalgia 12.21.9. Others 12.22. ASEAN Pain Management Drugs Market Forecast, By Brands 12.22.1. Maxalt 12.22.2. Zomig 12.22.3. Qutenza 12.22.4. Lidoderm 12.22.5. Savella 12.22.6. Imitrex 12.22.7. Voltaren Gel 12.22.8. Celebrex 12.22.9. Cymbalta 12.22.10. Others 12.23. Rest of Asia Pacific Pain Management Drugs Market Forecast, By Category 12.23.1. Prescription-Based Drugs 12.23.2. Over-The-Counter (OTC) Drugs 12.24. Rest of Asia Pacific Pain Management Drugs Market Forecast, By Therapeutic Indications 12.24.1. Post-Operative Pain 12.24.2. Low-Back Pain 12.24.3. Rheumatoid Arthritis Pain 12.24.4. Osteoarthritis Pain 12.24.5. Cancer Pain 12.24.6. Migraine 12.24.7. Neuropathic Pain 12.24.8. Fibromyalgia 12.24.9. Others 12.25. Rest of Asia Pacific Pain Management Drugs Market Forecast, By Brands 12.25.1. Maxalt 12.25.2. Zomig 12.25.3. Qutenza 12.25.4. Lidoderm 12.25.5. Savella 12.25.6. Imitrex 12.25.7. Voltaren Gel 12.25.8. Celebrex 12.25.9. Cymbalta 12.25.10. Others 12.26. Asia Pacific Pain Management Drugs Market Attractiveness Analysis 12.26.1. By Category 12.26.2. By Therapeutic Indications 12.26.3. By Brands 12.27. PEST Analysis 12.28. Key Trends 12.28.1. Key Developments 13. Middle East & Africa Pain Management Drugs Market Analysis 13.1. Middle East & Africa Pain Management Drugs Market Overview 13.2. Middle East & Africa Pain Management Drugs Market Value Share Analysis, By Category 13.3. Middle East & Africa Pain Management Drugs Market Forecast, By Category 13.3.1. Prescription-Based Drugs 13.3.2. Over-The-Counter (OTC) Drugs 13.4. Middle East & Africa Pain Management Drugs Market Value Share Analysis, By Therapeutic Indications 13.5. Middle East & Africa Pain Management Drugs Market Forecast, By Therapeutic Indications 13.5.1. Post-Operative Pain 13.5.2. Low-Back Pain 13.5.3. Rheumatoid Arthritis Pain 13.5.4. Osteoarthritis Pain 13.5.5. Cancer Pain 13.5.6. Migraine 13.5.7. Neuropathic Pain 13.5.8. Fibromyalgia 13.5.9. Others 13.6. Middle East & Africa Pain Management Drugs Market Value Share Analysis, By Brands 13.7. Middle East & Africa Pain Management Drugs Market Forecast, By Brands 13.7.1. Maxalt 13.7.2. Zomig 13.7.3. Qutenza 13.7.4. Lidoderm 13.7.5. Savella 13.7.6. Imitrex 13.7.7. Voltaren Gel 13.7.8. Celebrex 13.7.9. Cymbalta 13.7.10. Others 13.8. Middle East & Africa Pain Management Drugs Market Forecast, by Country 13.8.1. GCC 13.8.2. South Africa 13.8.3. Rest of Middle East & Africa 13.9. Middle East & Africa Pain Management Drugs Market Analysis, by Country/ Sub-region 13.10. GCC Pain Management Drugs Market Forecast, By Category 13.10.1. Prescription-Based Drugs 13.10.2. Over-The-Counter (OTC) Drugs 13.11. GCC Pain Management Drugs Market Forecast, By Therapeutic Indications 13.11.1. Post-Operative Pain 13.11.2. Low-Back Pain 13.11.3. Rheumatoid Arthritis Pain 13.11.4. Osteoarthritis Pain 13.11.5. Cancer Pain 13.11.6. Migraine 13.11.7. Neuropathic Pain 13.11.8. Fibromyalgia 13.11.9. Others 13.12. GCC Pain Management Drugs Market Forecast, By Brands 13.12.1. Maxalt 13.12.2. Zomig 13.12.3. Qutenza 13.12.4. Lidoderm 13.12.5. Savella 13.12.6. Imitrex 13.12.7. Voltaren Gel 13.12.8. Celebrex 13.12.9. Cymbalta 13.12.10. Others 13.13. Others South Africa Pain Management Drugs Market Forecast, By Category 13.13.1. Prescription-Based Drugs 13.13.2. Over-The-Counter (OTC) Drugs 13.14. South Africa Pain Management Drugs Market Forecast, By Therapeutic Indications 13.14.1. Post-Operative Pain 13.14.2. Low-Back Pain 13.14.3. Rheumatoid Arthritis Pain 13.14.4. Osteoarthritis Pain 13.14.5. Cancer Pain 13.14.6. Migraine 13.14.7. Neuropathic Pain 13.14.8. Fibromyalgia 13.14.9. Others 13.15. South Africa Pain Management Drugs Market Forecast, By Brands 13.15.1. Maxalt 13.15.2. Zomig 13.15.3. Qutenza 13.15.4. Lidoderm 13.15.5. Savella 13.15.6. Imitrex 13.15.7. Voltaren Gel 13.15.8. Celebrex 13.15.9. Cymbalta 13.15.10. Others 13.16. Rest of Middle East & Africa Pain Management Drugs Market Forecast, By Category 13.16.1. Prescription-Based Drugs 13.16.2. Over-The-Counter (OTC) Drugs 13.17. Rest of Middle East & Africa Pain Management Drugs Market Forecast, By Therapeutic Indications 13.17.1. Post-Operative Pain 13.17.2. Low-Back Pain 13.17.3. Rheumatoid Arthritis Pain 13.17.4. Osteoarthritis Pain 13.17.5. Cancer Pain 13.17.6. Migraine 13.17.7. Neuropathic Pain 13.17.8. Fibromyalgia 13.17.9. Others 13.18. Rest of Middle East & Africa Pain Management Drugs Market Forecast, By Brands 13.18.1. Maxalt 13.18.2. Zomig 13.18.3. Qutenza 13.18.4. Lidoderm 13.18.5. Savella 13.18.6. Imitrex 13.18.7. Voltaren Gel 13.18.8. Celebrex 13.18.9. Cymbalta 13.18.10. Others 13.19. Middle East & Africa Pain Management Drugs Market Attractiveness Analysis 13.19.1. By Category 13.19.2. By Therapeutic Indications 13.19.3. By Brands 13.20. PEST Analysis 13.21. Key Trends 13.21.1. Key Developments 14. South America Pain Management Drugs Market Analysis 14.1. South America Pain Management Drugs Market Overview 14.2. South America Pain Management Drugs Market Value Share Analysis, By Category 14.3. South America Pain Management Drugs Market Forecast, By Category 14.3.1. Prescription-Based Drugs 14.3.2. Over-The-Counter (OTC) Drugs 14.4. South America Pain Management Drugs Market Value Share Analysis, By Therapeutic Indications 14.5. South America Pain Management Drugs Market Forecast, By Therapeutic Indications 14.5.1. Post-Operative Pain 14.5.2. Low-Back Pain 14.5.3. Rheumatoid Arthritis Pain 14.5.4. Osteoarthritis Pain 14.5.5. Cancer Pain 14.5.6. Migraine 14.5.7. Neuropathic Pain 14.5.8. Fibromyalgia 14.5.9. Others 14.6. South America Pain Management Drugs Market Value Share Analysis, By Brands 14.7. South America Pain Management Drugs Market Forecast, By Brands 14.7.1. Maxalt 14.7.2. Zomig 14.7.3. Qutenza 14.7.4. Lidoderm 14.7.5. Savella 14.7.6. Imitrex 14.7.7. Voltaren Gel 14.7.8. Celebrex 14.7.9. Cymbalta 14.7.10. Others 14.8. South America Pain Management Drugs Market Value Share Analysis, by Country 14.9. South America Pain Management Drugs Market Forecast, by Country 14.9.1. Brazil 14.9.2. Mexico 14.9.3. Rest of South America 14.10. South America Pain Management Drugs Market Analysis, by Country/ Sub-region 14.11. Brazil Pain Management Drugs Market Forecast, By Category 14.11.1. Prescription-Based Drugs 14.11.2. Over-The-Counter (OTC) Drugs 14.12. Brazil Pain Management Drugs Market Forecast, By Therapeutic Indications 14.12.1. Post-Operative Pain 14.12.2. Low-Back Pain 14.12.3. Rheumatoid Arthritis Pain 14.12.4. Osteoarthritis Pain 14.12.5. Cancer Pain 14.12.6. Migraine 14.12.7. Neuropathic Pain 14.12.8. Fibromyalgia 14.12.9. Others 14.13. Brazil Pain Management Drugs Market Forecast, By Brands 14.13.1. Maxalt 14.13.2. Zomig 14.13.3. Qutenza 14.13.4. Lidoderm 14.13.5. Savella 14.13.6. Imitrex 14.13.7. Voltaren Gel 14.13.8. Celebrex 14.13.9. Cymbalta 14.13.10. Others 14.14. Mexico Pain Management Drugs Market Forecast, By Category 14.14.1. Prescription-Based Drugs 14.14.2. Over-The-Counter (OTC) Drugs 14.15. Mexico Pain Management Drugs Market Forecast, By Therapeutic Indications 14.15.1. Post-Operative Pain 14.15.2. Low-Back Pain 14.15.3. Rheumatoid Arthritis Pain 14.15.4. Osteoarthritis Pain 14.15.5. Cancer Pain 14.15.6. Migraine 14.15.7. Neuropathic Pain 14.15.8. Fibromyalgia 14.15.9. Others 14.16. Mexico Pain Management Drugs Market Forecast, By Brands 14.16.1. Maxalt 14.16.2. Zomig 14.16.3. Qutenza 14.16.4. Lidoderm 14.16.5. Savella 14.16.6. Imitrex 14.16.7. Voltaren Gel 14.16.8. Celebrex 14.16.9. Cymbalta 14.16.10. Others 14.17. Rest of South America Pain Management Drugs Market Forecast, By Category 14.17.1. Prescription-Based Drugs 14.17.2. Over-The-Counter (OTC) Drugs 14.18. Rest of South America Pain Management Drugs Market Forecast, By Therapeutic Indications 14.18.1. Post-Operative Pain 14.18.2. Low-Back Pain 14.18.3. Rheumatoid Arthritis Pain 14.18.4. Osteoarthritis Pain 14.18.5. Cancer Pain 14.18.6. Migraine 14.18.7. Neuropathic Pain 14.18.8. Fibromyalgia 14.18.9. Others 14.19. Rest of South America Pain Management Drugs Market Forecast, By Brands 14.19.1. Maxalt 14.19.2. Zomig 14.19.3. Qutenza 14.19.4. Lidoderm 14.19.5. Savella 14.19.6. Imitrex 14.19.7. Voltaren Gel 14.19.8. Celebrex 14.19.9. Cymbalta 14.19.10. Others 14.20. South America Pain Management Drugs Market Attractiveness Analysis 14.20.1. By Category 14.20.2. By Therapeutic Indications 14.20.3. By Brands 14.21. PEST Analysis 14.22. Key Trends 14.22.1. Key Developments 15. Company Landscape 15.1. Market Share Analysis, by Company 15.2. Competition Matrix 15.3. Competitive Benchmarking of Company and Services 15.4. Company Profiles: Key Players 15.4.1. Pfizer, Inc. 15.4.1.1. Company Overview 15.4.1.2. Financial Overview 15.4.1.3. Business Strategy 15.4.1.4. Recent Developments 15.4.1.5. Development Footprint 15.4.2. Purdue Pharma L.P. 15.4.3. Eli Lilly And Company 15.4.4. GlaxoSmithKline 15.4.5. Johnson & Johnson 15.4.6. Endo Pharmaceuticals 15.4.7. Allergen Inc. 15.4.8. Bayer AG 15.4.9. Bristol-Myers Squibb 15.4.10. Valeant Pharmaceuticals International Inc. 15.4.11. Boehringer Ingelheim 15.4.12. Sorrento Therapeutics 15.4.13. WEX Pharmaceuticals 15.4.14. Zynerba Pharmaceuticals 15.4.15. GSK 15.4.16. Grunenthal 15.4.17. AstraZeneca 15.4.18. Depomed 15.4.19. Teva 15.4.20. Allergan 16. Primary Key Insights

About This Report

Report ID 23895
Category Healthcare
Published Date Oct 2022
Updated Date
Contact Us